لابراتوارهای سینادارو
دسینا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 92,200 1.60
Close Price: 92,130
Financial Ratios
AGM
Interim
2026/06/21 Fiscal Year 2026/03/2012 Month | 2025/07/07 Fiscal Year 2025/03/2012 Month | 2024/07/13 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 45.75 | 39.89 | 32.49 | |
Gross Profit to Sales | 54.14 | 47.11 | 41.38 | |
Operating Margin | 54.54 | 49.33 | 44.25 | |
Gross Profit to Sales | 58.69 | 54.41 | 48.61 | |
Net Profit to Gross Profit | 77.95 | 73.32 | 66.84 | |
Return on Assets (ROA) | 47.07 | 39.28 | 31.55 | |
Return on Capital (%) | 804.64 | 401.66 | 234.78 | |
Return on Equity (ROE) | 66.3 | 61.29 | 56.2 | |
Working Capital Return | 73.94 | 77.42 | 97.65 | |
Fixed Asset Return | 397.87 | 222.53 | 114.88 | |
Loan Benefit Assessment | 1.41 | 1.56 | 1.78 | |
Current Ratio | 3.61 | 2.61 | 1.81 | |
Quick Ratio | 2.76 | 1.82 | 1.17 | |
Liquidity Ratio | 0.7 | 0.27 | 0.1 | |
Net Working Capital | 26,119,020 | 12,451,116 | 5,770,401 | |
Current Assets Ratio | 0.88 | 0.82 | 0.72 | |
Inventory Turnover | 153.44 | 176.79 | 140.25 | |
Receivables Collection Period | 130.02 | 148.97 | 105.52 | |
Inventory to Working Capital | 0.33 | 0.49 | 0.79 | |
Working Capital Turnover | 1.62 | 1.94 | 3.01 | |
Fixed Asset Turnover | 8.7 | 5.58 | 3.54 | |
Total Asset Turnover | 1.03 | 0.98 | 0.97 | |
Debt Ratio | 0.29 | 0.36 | 0.44 | |
Debt to Equity | 0.41 | 0.56 | 0.78 | |
Long-Term Debt to Equity | 0.06 | 0.07 | 0.07 | |
Current Debt to Equity | 0.34 | 0.49 | 0.71 | |
Equity Ratio | 70.99 | 64.08 | 56.14 | |
Debt Coverage Ratio | 2.58 | 3.96 | 7.13 |
